ActivePharmaceutical

IngredientsCatalog

2021

T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL

Canagli�ozin*

Dapagli�ozin*

Empagli�ozin*

Glimepiride

Linagliptin

PioglitazoneHydrochloride

SitagliptinHydrochloride

SitagliptinPhosphate*

ANTI

-DIA

BETI

C

Available

Available

Available

Available

Available

Available

Available

Available

Liraglutide Available

Semaglutide UD

Gati�oxacin

Levo�oxacinHemihydrateMoxi�oxacin

Hydrochloride

Posaconazole

Terbina�neHydrochloride

Voriconazole

AmlodipineBesylate

Apixaban

AtorvastatinCalcium*

ClopidogrelBisulfate*

DabigatranEtexilate Mesylate

DoxazosinMesylate

EnalaprilMaleate

FondaparinuxSodium

Irbesartan

CARD

IOVA

SCUL

ARAN

TI-I

NFEC

TIVE

Available

Available

Available

Available

Available

Available

Available

Available

Available

Candesartan Available

Available

Available

Available

Available

Available

Available

Iron Sucrose(Available for selected markets)

Lacidipine

Available

Available

LosartanPotassium Available

HCQS Available

ClopidogrelForm 2 Available

T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL

Ranolazine

Rivaroxaban

Sacubitril /Valsartan

Telmisartan

Ticagrelor

Treprostinil

Valsartan

AsenapineMaleate

AtomoxetineHydrochloride

BenztropineMesylate

Dimethyl Fumarate

Divalproex Sodium

Donepezil HCl

EscitalopramOxalate

EslicarbazepineAcetate

Eszopiclone

FingolimodHydrochloride

Glatiramer Acetate

Levetiracetam

LurasidoneHydrochloride

CENT

RAL

NERV

OUS

SYST

EMCA

RDIO

VASC

ULAR

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

UD

Ferric Carboxymaltose (Available for selected markets)

Ferumoxytol(Available for selected markets)

UD

UD

Bempedoic Acid

UDTafamidisFree Acid

UDTafamidisMeglumine

Ramipril Available

AvailableEdaravone

Roxadustat* Available

MetoprololSuccinate Available

UDEnalaprilat

AvailableDiroximel Fumarate

T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL

RivastigmineHydrogen Tartrat

TizanidineHydrochloride

VilazodoneHydrochloride

ZiprasidoneHydrochloride

EsomeprazoleMagnesium*

Famotidine

Lubiprostone

Nizatidine

Obeticholic Acid

Omeprazole

OmeprazoleMagnesium

PantoprazoleSodium

RabeprazoleSodium*

Apremilast*

RaloxifeneHydrochloride

AbirateroneAcetate

Azacitidine

BendamustineHydrochloride

Bortezomib

Cabazitaxel

Capecitabine

ONCO

LOGY

GAST

RO-I

NTES

TINA

LCE

NTRA

L NE

RVOU

S SY

STEM

MUS

CULO

-SK

ELET

AL

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Siponimod* UD

VenlafaxineHydrochloride UD

Lumateperone UD

Abaloparatide UD

QuetiapineFumarate

Risperidone

Available

Available

Pregabalin Available

Olanzapine Available

Apalutamide* Available

MemantineHydrochloride Available

T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL

Enzalutamide*

GemcitabineHydrochloride

Granisteron

IbandronateSodium

Ibrutinib*

Lenalidomide*

Lenvatinib*

Lomustine

NilotinibHydrochloride*

(Available for selected markets)

OndansetronHydrochloride

Palbociclib

PalonosetronHydrochloride

PemetrexedDisodium*

PemetrexedDitromethamine

Plerixafor

Pomalidomide

Venetoclax

Zoledronic Acid

Eribulin(Available for selected markets)

Fosaprepitant

Midostaurin*

ONCO

LOGY

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

OndansetronBase Available

Available

Available

Available

Available

Available

Available

Available

Available

UD

UD

Available

Available

Available

Olaparib*

Pazopanib

UDRuxolitinibPhosphate*

Docetaxel Available

Decitabine Available

Car�lzomib Available

Dasatinib(Available for selected markets) Available

UDCabozantinibS-Malate

UDIcotinib HCl

UDRelugolix

T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZILT H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL

CetirizineDihydrochloride

Desloratadine

FexofenadineHydrochloride*Levocetirizine

Dihydrochloride

MontelukastSodium

Za�rlukast

Dutasteride

EliglustatHemitartrate

Febuxostat

Finasteride*

Mirabegron*

Testosterone

Icatibant Acetate

Li�tegrast

Permethrin

SugammadexSodium

Pidotimod

UROL

OGY

RESP

IRAT

ORY

OTHE

RS

KetorolacTromethamine

Naproxen

NaproxenSodium

NaratriptanHydrochloride

SumatriptanSuccinate

PAIN

MAN

AGEM

ENT

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

UD

Remdesivir*(Available for selected markets) UD

UD

UD

Tofacitinib

Varenicline Tartrate

Elagolix Sodium Available

CinacalcetHydrochloride Available

Salcaprozpate Sodium (SNAC)

(Excipient for Oral Semaglutide)UD

Ivermectin UD

OTHER PIPELINE PRODUCTS

Development timeline to be checked with the Sales Manager

PRODUCT NAMETHERAPY AREA DR. REDDY’S IP ORAL INJ

Alpelisib

Mavacamten

Repretinib

ONCOLOGY

CENTRAL NERVOUS SYSTEM

CARDIOVASCULAR

Viloxazine HCl

OTHERS Risdepalm

Disclaimer: No information in this catalog - including any reference to any product or service - constitutes an o�er for sale, or be construed as representing an o�er for sale. Products protected under valid patents are not o�ered or supplied for commercial use. However, the research quantities of such products may be o�ered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.

Cedazuridine